COMPLEMENT ACTIVATION BY THROMBOLYTIC AGENTS IN ACUTE MYOCARDIAL-INFARCTION - A COMPARISON BETWEEN STREPTOKINASE (SK) AND RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR (RT-PA)

被引:0
|
作者
GARDINALI, M
FRANGI, D
CUGNO, M
CONCIATO, L
CAFARO, C
SPONZILLI, C
AGOSTONI, A
机构
[1] UNIV MILAN,INST INTERNAL MED,I-20122 MILAN,ITALY
[2] SAN PALO HOSP,DIV CARDIOL,MILAN,ITALY
来源
CLINICAL RESEARCH | 1994年 / 42卷 / 02期
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:A193 / A193
页数:1
相关论文
共 50 条
  • [31] PREHOSPITAL THROMBOLYTIC TREATMENT OF ACUTE MYOCARDIAL-INFARCTION WITH ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX
    BOSSAERT, LL
    DEMEY, HE
    COLEMONT, LJ
    BEAUCOURT, L
    FIERENS, H
    DIRIX, L
    PINTENS, H
    MORTSEL, HR
    CRITICAL CARE MEDICINE, 1988, 16 (09) : 823 - 830
  • [32] EVALUATION OF 2 INTRAVENOUS THROMBOLYTIC AGENTS (ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX VERSUS STREPTOKINASE) IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    SEABRAGOMES, R
    SILVA, JA
    ALEIXO, A
    REAL, T
    FREIRE, I
    TORRES, I
    FREITAS, R
    CRESPO, F
    DRUGS, 1987, 33 : 169 - 174
  • [33] COST-EFFECTIVENESS OF THROMBOLYTIC THERAPY WITH TISSUE-PLASMINOGEN ACTIVATOR AS COMPARED WITH STREPTOKINASE FOR ACUTE MYOCARDIAL-INFARCTION (VOL 332, PG 1418, 1995)
    MARK, DB
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (04): : 267 - 267
  • [34] RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR (RT-PA) AS FIRST-LINE THERAPY FOR DECLOTTING OF HEMODIALYSIS ACCESS
    ANDRIANI, M
    DRAGO, G
    BERNARDI, AM
    DAPORTO, A
    DELUCA, M
    RIEGLER, P
    BIASIA, F
    PINZANI, A
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (09) : 1714 - 1719
  • [35] Thrombolytic therapy of prosthetic valve thrombosis with recombinant tissue plasminogen activator (rt-PA) in infancy and childhood
    Serpi, M
    Schmidt, KG
    Kreuz, W
    Bucsenez, D
    Springer, W
    Hagl, S
    Ulmer, HE
    ZEITSCHRIFT FUR KARDIOLOGIE, 2001, 90 (03): : 191 - +
  • [36] A COMPARISON BETWEEN INTRAVENOUS STREPTOKINASE AND TISSUE PLASMINOGEN-ACTIVATOR WITH EARLY INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
    CHERNG, WJ
    CHIANG, CW
    KUO, CT
    LEE, CP
    LEE, YS
    AMERICAN HEART JOURNAL, 1992, 123 (04) : 841 - 846
  • [37] TISSUE-PLASMINOGEN ACTIVATOR (T-PA) IN MYOCARDIAL-INFARCTION - BIOCHEMICAL-CHANGES
    SAMAMA, M
    VERDY, E
    CONARD, J
    VAHANIAN, A
    MICHEL, P
    VANDREDEN, P
    NGUYEN, G
    HORELLOU, MH
    COMBRISSON, A
    ACAR, J
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1986, 79 (04): : 532 - 532
  • [38] EARLY AND LATE EXERCISE CAPACITY AFTER ACUTE MYOCARDIAL-INFARCTION TREATED WITH RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR
    BRZOSTEK, T
    VANDEWERF, F
    MORTELMANS, L
    SCHEYS, I
    LESAFFRE, E
    DUBIEL, JS
    DEGEEST, H
    EUROPEAN HEART JOURNAL, 1994, 15 (05) : 641 - 647
  • [39] Results of recombinant tissue plasminogen activator (rt-PA) usage in the treatment of cerebral infarction (CI)
    Enina, G.
    Miglane, E.
    Tilgale, B.
    Slosberga, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 65 - 66
  • [40] The state of lipid peroxidation and antioxidants following thrombolytic therapy with rt-PA and streptokinase in acute myocardial infarction
    Özmen, D
    Boydak, B
    Mutaf, I
    Zoghi, M
    Kumanlioglu, K
    Güner, I
    Bayindir, O
    JAPANESE HEART JOURNAL, 1999, 40 (03): : 267 - 273